BofA Securities Starts Neumora Therapeutics (NMRA) at Buy; 'emerging neuro powerhouse'
Tweet Send to a Friend
(Updated - October 10, 2023 6:30 AM EDT)
BofA Securities analyst Geoff Meacham initiates coverage on Neumora Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Geoff Meacham initiates coverage on Neumora Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
